These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17685251)

  • 21. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
    Houssami N; Ambrogetti D; Marinovich ML; Bianchi S; Macaskill P; Vezzosi V; Mamounas EP; Ciatto S
    Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: detection with MR imaging.
    Cooney BS; Orel SG; Schnall MD; Troupin RH
    AJR Am J Roentgenol; 1994 Jun; 162(6):1318-20. PubMed ID: 8191990
    [No Abstract]   [Full Text] [Related]  

  • 23. Histological assessment of breast lesions identified exclusively by magnetic resonance.
    O'Connor V; Arena E; Albright J; Brown N; O'Connor R; Chung M; DiNome M; Shamonki J
    Am Surg; 2014 Oct; 80(10):944-7. PubMed ID: 25264635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of breast cancer.
    Watkins EJ
    JAAPA; 2019 Oct; 32(10):13-17. PubMed ID: 31513033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apocrine Ductal Carcinoma In Situ Presenting as a Large, Cystic Breast Mass: An Uncommon Presentation of a Rare Breast Lesion.
    Seo KJ; Whang IY
    Breast J; 2017 Sep; 23(5):594-595. PubMed ID: 28252232
    [No Abstract]   [Full Text] [Related]  

  • 26. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging of the skin and nipple of the breast: differentiation between tumour recurrence and post-treatment change.
    Ralleigh G; Walker AE; Hall-Craggs MA; Lakhani SR; Saunders C
    Eur Radiol; 2001; 11(9):1651-8. PubMed ID: 11511886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
    Liu TT; Li XF; Wang L; Yang JL
    Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?].
    Teifke A; Vomweg TW; Hlawatsch A; Nasresfahani A; Kern A; Victor A; Schmidt M; Bittinger F; Düber C
    Rofo; 2006 Mar; 178(3):330-6. PubMed ID: 16508842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
    Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
    Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
    Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
    Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast procedures guided by magnetic resonance imaging.
    David J; Trop I; Lalonde L
    Can Assoc Radiol J; 2005 Dec; 56(5):309-18. PubMed ID: 16579025
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of routine cavity shave margins on breast cancer re-excision rates.
    Kobbermann A; Unzeitig A; Xie XJ; Yan J; Euhus D; Peng Y; Sarode V; Moldrem A; Marilyn Leitch A; Andrews V; Stallings C; Rao R
    Ann Surg Oncol; 2011 May; 18(5):1349-55. PubMed ID: 21046260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast Cancer following Augmentation Mammaplasty: A Case-Control Study.
    Sosin M; Devulapalli C; Fehring C; Hammond ER; Willey SC; Tousimis EA; Spear SL; Nahabedian MY; Feldman ED
    Plast Reconstr Surg; 2018 Apr; 141(4):833-840. PubMed ID: 29595718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer.
    Mariscotti G; Houssami N; Durando M; Bergamasco L; Campanino PP; Ruggieri C; Regini E; Luparia A; Bussone R; Sapino A; Fonio P; Gandini G
    Anticancer Res; 2014 Mar; 34(3):1219-25. PubMed ID: 24596363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Magnetic resonance mammography--open questions].
    Kessler M; Sittek H; Reiser M
    Geburtshilfe Frauenheilkd; 1996 Aug; 56(8):M107-15. PubMed ID: 8974887
    [No Abstract]   [Full Text] [Related]  

  • 37. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
    Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rates of pathological underestimation for 9 and 12 gauge breast needle core biopsies at surgical excision.
    Destounis S; Skolny MN; Morgan R; Arieno A; Murphy PF; Somerville P; Seifert P; Young W
    Breast Cancer; 2011 Jan; 18(1):42-50. PubMed ID: 20204553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
    Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
    Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Not all ductal carcinoma in situ is created equal: can we avoid surgery for low-risk ductal carcinoma in situ?
    Lippey J; Spillane A; Saunders C
    ANZ J Surg; 2016 Nov; 86(11):859-860. PubMed ID: 27784140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.